Respiratory Syncytial Virus (RSV) Infection - Causes, Treatment & When to See a Doctor

```html

What is Respiratory Syncytial Virus (RSV) Infection?

Respiratory syncytial virus (RSV) is a common RNA virus that infects the respiratory tract of people of all ages. While most healthy adults experience only mild cold‑like symptoms, RSV is a leading cause of bronchiolitis and pneumonia in infants, young children, and older adults with compromised immunity or chronic lung disease. The virus spreads through respiratory droplets, contaminated surfaces, and close personal contact, making it especially prevalent during the fall, winter, and early spring in temperate climates.

According to the CDC, nearly all children are infected with RSV by the age of two, and reinfection can occur throughout life because immunity is only partial and short‑lived.

Common Causes

RSV infection itself is a single viral cause, but the term “causes” here refers to the contexts or risk factors that increase the likelihood of acquiring the virus or developing severe disease. The most important contributors include:

• Close contact with an infected person – family members, daycare peers, or healthcare workers.
• Seasonal peaks – RSV activity surges from November to March in the Northern Hemisphere.
• Premature birth – infants born before 37 weeks have under‑developed lungs and weaker immune defenses.
• Chronic lung disease – such as bronchopulmonary dysplasia or cystic fibrosis.
• Congenital heart disease – especially lesions that cause pulmonary over‑circulation.
• Immunocompromised state – due to chemotherapy, HIV/AIDS, or immunosuppressive medications.
• Exposure to tobacco smoke – both active smoking and second‑hand smoke increase airway inflammation.
• Living in crowded settings – daycare centers, nursing homes, and multi‑generational households facilitate transmission.
• Low socioeconomic status – associated with limited access to preventive care and crowded housing.
• Underlying neuromuscular disorders – that impair effective coughing or clearing of secretions.

Associated Symptoms

RSV infection can present with a spectrum ranging from mild upper‑respiratory illness to life‑threatening lower‑respiratory disease. Commonly reported symptoms include:

• Runny or stuffy nose
• Sore throat
• Dry cough that may become productive
• Fever (often low grade, 38 °C/100.4 °F)
• Wheezing and rapid breathing
• Chest retractions (skin pulling in around the ribs or neck)
• Difficulty feeding in infants (due to increased work of breathing)
• irritability or lethargy
• Decreased urine output (a sign of dehydration)

When to See a Doctor

Most healthy adults can manage mild RSV at home, but certain signs warrant prompt medical evaluation:

• Persistent high fever (> 39 °C / 102 °F) lasting more than 3 days.
• Worsening cough or wheeze that interferes with sleep or feeding.
• Rapid breathing (more than 60 breaths per minute in infants, > 30 in toddlers, > 20 in adults) or visible chest retractions.
• Blue‑tinged lips or fingertips (cyanosis).
• Signs of dehydration – dry mouth, no tears when crying, fewer than six wet diapers per day.
• New or worsening difficulty breathing in someone with heart or lung disease.
• Any infant younger than 3 months with fever, trouble breathing, or poor feeding.

If you or your child exhibit any of these, contact a healthcare provider immediately. Early intervention can prevent complications such as respiratory failure.

Diagnosis

Clinicians use a combination of history, physical examination, and laboratory testing to confirm RSV infection.

Clinical Evaluation

• History – recent exposure to sick contacts, season, and underlying health conditions.
• Physical exam – listening for wheezes, crackles, and assessing respiratory effort.

Laboratory Tests

• Rapid antigen detection test (often a nasal swab) – provides results in 15–30 minutes, with sensitivity ranging from 70‑90 %.
• Polymerase chain reaction (PCR) – more sensitive than antigen tests; can differentiate RSV from other respiratory viruses.
• Complete blood count (CBC) – may show mild leukocytosis or lymphopenia.
• Chest X‑ray – reserved for patients with signs of lower‑respiratory involvement (e.g., persistent wheeze, high fever, or suspected pneumonia).

Special Considerations

In high‑risk infants (premature, congenital heart disease, or chronic lung disease), clinicians may order a pulse oximetry test to measure blood oxygen saturation. A reading < 92 % often prompts supplemental oxygen therapy.

Treatment Options

There is no specific antiviral cure for RSV in most patients. Management focuses on supportive care, with targeted therapies for high‑risk groups.

Supportive Care (Home)

• Increase fluid intake – breast milk, formula, or water for older children/adults.
• Use a cool‑mist humidifier to ease breathing.
• Elevate the head of the crib or bed to reduce nasal congestion.
• Saline nasal drops or sprays to clear nasal passages.
• Acetaminophen or ibuprofen for fever and discomfort (avoid aspirin in children).
• Monitor breathing rate and temperature at least twice daily.

Medical Interventions

• Supplemental oxygen – via nasal cannula or mask for patients with low O₂ saturation.
• Bronchodilators – trial of albuterol may help wheezing, though evidence is mixed.
• Respiratory support – high‑flow nasal cannula, continuous positive airway pressure (CPAP), or mechanical ventilation in severe cases.
• Palivizumab (Synagis) – a monoclonal antibody given monthly during RSV season to high‑risk infants (premature < 29 weeks, chronic lung disease, congenital heart disease). Not a treatment, but prophylaxis.
• Ribavirin – an antiviral inhaled medication reserved for severely immunocompromised patients; use is limited due to modest benefit and toxicity.

When Hospitalization Is Needed

Infants with apnea, severe dehydration, or inability to maintain oxygen saturation > 90 % typically require inpatient care. Adults with COPD, heart failure, or significant hypoxia also benefit from hospital observation.

Prevention Tips

Because RSV spreads easily, especially in indoor settings, adopting preventive measures can markedly reduce infection risk.

• Hand hygiene – Wash hands with soap and water for at least 20 seconds; use alcohol‑based sanitizer when washing isn’t feasible.
• Avoid close contact with sick individuals, especially during peak season.
• Clean surfaces regularly (doorknobs, toys, countertops) with EPA‑approved disinfectants.
• Limit exposure for high‑risk infants – keep them out of crowded daycare settings during RSV season.
• No smoking – eliminate tobacco use and avoid second‑hand smoke.
• Use protective equipment – healthcare workers should wear masks and eye protection when caring for RSV patients.
• Vaccination research – Several RSV vaccine candidates are in late‑phase trials (2024‑2025). Stay informed about future recommendations.
• Palivizumab prophylaxis – Discuss with your pediatrician if your infant qualifies.

Emergency Warning Signs

Bottom Line

Respiratory syncytial virus is a ubiquitous pathogen that can cause mild cold‑like symptoms in healthy adults but poses a serious threat to infants, the elderly, and people with chronic heart or lung disease. Early recognition of worsening breathing patterns, prompt medical evaluation, and supportive care are the cornerstones of management. Preventive measures—particularly rigorous hand hygiene and limiting exposure during peak season—remain the most effective tools we have while research moves toward an RSV vaccine.

References:

• Mayo Clinic. “Respiratory Syncytial Virus (RSV)”. https://www.mayoclinic.org
• Centers for Disease Control and Prevention. “RSV – Respiratory Syncytial Virus”. https://www.cdc.gov
• National Institutes of Health. “RSV Infection in Infants and Children”. https://www.nichd.nih.gov
• Cleveland Clinic. “RSV (Respiratory Syncytial Virus)”. https://my.clevelandclinic.org
• World Health Organization. “Respiratory syncytial virus – epidemiology and prevention”. https://www.who.int

```